Dysfunction of T helper 17 (Th17) cells leads to chronic inflammatory disorders. Signal transducer and activator of transcription 3 (STAT3) orchestrates the expression of proinflammatory cytokines and pathogenic cell differentiation from interleukin (IL)-17-producing Th17 cells. However, the pathways mediated by STAT3 signaling are not fully understood. Here, we observed that Fos-related antigen 1 (FRA1) and JUNB are directly involved in STAT3 binding to sites in the promoters of Fosl1 and Junb. Promoter binding increased expression of IL-17 and the development of Th17 cells. Overexpression of Fra1 and Junb in mice resulted in susceptibility to collagen-induced arthritis and an increase in Th17 cell numbers and inflammatory cytokine production. In patients with rheumatoid arthritis, FRA1 and JUNB were colocalized with STAT3 in the inflamed synovium. These observations suggest that FRA1 and JUNB are associated closely with STAT3 activation, and that this activation leads to Th17 cell differentiation in autoimmune diseases and inflammation.
inTrODUcTiOn T helper 17 (Th17) cells are a pathogenic subset of T helper lymphocytes that play a key role in inflammatory disorders leading to a severe chronic immune inflammatory response. Th17 cells release several proinflammatory cytokines including interleukin (IL)-17A, IL-21, and IL-22 (1) . IL-17A is an inflammatory cytokine produced predominantly by Th17 cells with strong effects on stromal cells. IL-17A induces inflammatory cytokine production and leukocyte recruitment, which act to link the innate and adaptive branches of immunity (2) . Both IL-17A and Th17 cells are highly involved in the pathogenesis of several autoimmune diseases, including rheumatoid arthritis (RA) (3, 4) , while playing a significant role in autoimmune disorders mediated by excessive inflammation. Signal transducer and activator of transcription 3 (STAT3) is an important transcription factor with DNA-binding properties whose activity is paramount to the inflammatory response. It has been suggested that STAT3 activation upregulates IL-17 production via Th17 cell proliferation (5, 6) . Several transcription factors including STAT3 regulate Th17 cell differentiation (7) (8) (9) (10) (11) (12) ; however, STAT3 also plays a key role in the immune inflammatory response. There is a general consensus that STAT3 is essential for Th17 cell differentiation (13) . Moreover, STAT3 modulates the production of several cytokines including IL-17A and activates downstream transcription factors, such as RAR-related orphan receptor gamma isoform 2 (RORγt), which is responsible for the Th17 phenotype (14, 15) .
The activator protein 1 (AP-1) family is a group of structurally and functionally related JUN (c-JUN, JUNB, and JUND) and FOS [c-FOS, FOSB, Fos-related antigen 1 (FRA1), and FRA2] transcription factors. AP-1 heterodimers are involved in a variety of biological processes including cell proliferation, differentiation, apoptosis, and inflammation (16, 17) . It has been suggested that AP-1 proteins are involved in several pathological conditions (18) (19) (20) (21) , while JUN and FOS proteins are also associated with the immune inflammatory response. Modulation of c-FOS and c-JUN expression is critical for inhibition of IL-17 production (22) and the maintenance of suppressive regulatory T-cell function (23) . Additionally, production of FRA1, a member of the FOS protein family, is increased by B cell stimulation (24) . Furthermore, JUNB modulates the proliferation of B cells (25) . This evidence suggests that FRA1 and JUNB may be involved in regulating the inflammatory immune response.
We hypothesized that FRA1 and JUNB modulate the Th17 cell-mediated inflammatory response. The aim of this study was to elucidate whether FRA1 and JUNB regulate autoimmune arthritis via Th17 cell differentiation and factors downstream of STAT3. We used in vitro models, in vivo animal models, and clinical specimens from patients with RA to investigate the biological importance of this pathway.
MaTerials anD MeThODs

Mice
Collagen-induced arthritis (CIA) was induced in 6-8-week-old male DBA/1J, BALB/c, and C57BL/6 mice (Orient, Korea).
To generate Fra1/Junb Tg mice, a pcDNA3.1+HA (Invitrogen, CA, USA) vector containing the FRA1 and JUNB proteins coupled to a linker peptide (3 × GGGGS) was constructed. The Fra1/Junb fragment was synthesized by GenScript Corporation (NJ, USA), with codon optimization for expression in mammalian cells. Fra1/Junb Tg mice were bred from the C57BL/6 line and maintained in facilities at Macrogen Laboratories (Seoul, Korea). All mice were maintained under specific-pathogen-free conditions at the Institute of Medical Science, The Catholic University of Korea. The presence of the transgene in the founders was confirmed by PCR of genomic DNA extracted from the tail samples. Genotyping was performed by PCR analysis of genomic DNA obtained from mice at 3 weeks of age. All experimental procedures were examined and approved by the Animal Research Ethics Committee at the Catholic University of Korea.
accession codes
Raw RNA-seq data have been deposited in the NCBI Sequence Read Archive (SRR6320798 and SRR6320799).
A detailed description of all other experimental procedures and the statistical analysis is provided in the Section "Supplementary Materials and Methods" in Data Sheet S1 in Supplementary Material.
resUlTs sTaT3 Target genes are Differentially expressed in Mouse Th17 cells
Potential STAT3-binding sites were identified using publicly available chromatin immunoprecipitation sequencing (ChIP-Seq) data cross-referenced with differentially expressed genes in Th17 cells (14) . We sequenced mRNA obtained from Th17 cells and naïve T cells and compared the results with potential STAT3-binding targets identified by ChIP-Seq to identify STAT3-regulated genes involved in Th17 cell differentiation. The literature was systematically reviewed for downstream STAT3 targets in humans and mice in multiple biological contexts. By combining these three datasets, we searched for genes with STAT3-binding sites that are upregulated during Th17 cell differentiation ( Figure 1A ; expression. Among the various AP-1 subtypes, only Fra1 and Junb mRNA levels were significantly increased in Th17 cells compared with naive T cells (Figures 2A,B) . These findings supported the RNA-Seq results. Immunoblot analysis also showed high levels of FRA1 and JUNB expression in Th17 cells ( Figure 2C) . Co-immunoprecipitation studies were performed using antibodies against Jun family proteins (i.e., JUNB and c-JUN), followed by immunoblotting using antibodies against FOS family proteins (i.e., FRA1, c-FOS, and FOSB) to determine whether FRA1 and JUNB form a heterodimeric AP-1 complex. It was found that FRA1 forms a complex with JUNB, but not with c-JUN ( Figure 2D) . Next, we investigated the functional association between the FRA1-JUNB complex and STAT3. The STAT3 signaling pathway was inhibited using genetically engineered STAT3-deficient CD4 + T cells and STA-21, which blocks the DNA-binding activity of STAT3 (26) . As shown in Figure 3A Co-immunoprecipitation studies were performed using anti-FRA1 and anti-JUNB antibodies followed by immunoblotting with antibodies against STAT3 to determine whether FRA1 and JUNB physically interact with STAT3. Both FRA1 and JUNB were found to form a complex with STAT3 ( Figure 3F ). We performed ChIP and qPCR to examine whether STAT3 binds directly to the promoter regions of Fosl1 and Junb. The ChIPqPCR results were compared with publicly available ChIP-Seq data from Th17 cells. We found that STAT3 binds to the predicted recognition sites upstream of Fosl1 and Junb, suggesting that it regulates their expression by binding directly to their promoters ( Figure 3G) . Using confocal microscopy, we found that FRA1 and JUNB were colocalized with phosphorylated STAT3 in CD4
+ splenic T cells and Th17 cells from arthritic mice (Figures 3H,I ). These findings suggest that STAT3 signaling is critical for the expression and activation of FRA1 and JUNB during Th17 cell differentiation. The AP-1 family plays a versatile role in T-cell development (27) . Levels of IL-17 were measured in Fra1-and Junb-overexpressing and silenced cells. The relative levels of IL17 mRNA were significantly increased in cells overexpressing Fra1 and Junb. The relative mRNA levels of other genes associated with Th17 cells, such as IL21, IL22, and Rorc (the RORγt gene locus), were also increased ( Figures 4A,B) . CD4 + IL-17 + cells and IL17 mRNA levels were significantly decreased when Fra1 and Junb were silenced under Th17-polarizing conditions (Figures 4C,D) . By contrast, when c-Fos and c-Jun, the dominant AP-1 subtypes in naïve T cells, were overexpressed, IL17 mRNA levels were decreased significantly (Figures 4E,F) . These findings support the specificity of the role of the FRA1-JUNB complex in Th17 cell differentiation.
We next investigated whether the FRA1-JUNB complex directly regulates IL-17 expression by binding to the IL17a promoter. The interaction between the FRA1-JUNB complex and the AP-1-binding motif within the IL17a promoter region was examined by electrophoretic mobility shift assay. The anti-FRA1 and anti-JUNB antibodies caused a super shift of the labeled DNA probe, indicating that the AP-1-binding motif interacts specifically with FRA1 and JUNB ( Figure 4G ). This finding was confirmed by an analysis of the IL17a promoter using a luciferase reporter system. Overexpression of both FRA1 and JUNB increased luciferase activity in EL4 cells. Simultaneous overexpression of FRA1 and JUNB caused luciferase activity to increase twofold ( Figure 4H) . Silencing of Fra1 and Junb caused a greater than twofold reduction in luciferase activity. Simultaneous overexpression of c-FOS and c-JUN caused a significant decrease in the luciferase activity induced by the IL17a promoter ( Figure 4I) . ChIP-qPCR analyses showed that FRA1 and JUNB bind directly to the IL17a gene loci and to gene loci encoding other Th17 cell differentiation activators, such as IL21, IL22, and Rorc ( Figure 4J ). These findings indicate that the FRA1-JUNB complex binds to (a,D,e,g ). The data were analyzed using an unpaired t-test; error bars show the SEM. *p < 0.05, **p < 0.005, and ***p < 0.0005. + T cells were cultured under Th17-polarizing conditions. Chromatin immunoprecipitation-qPCR was performed using anti-FRA1 or anti-JUNB antibodies with primers specific for each gene locus. Data are representative of at least three independent experiments, performed in triplicate. Data were analyzed using an unpaired t-test; error bars show the SEM. *p < 0.05, **p < 0.005, and ***p < 0.0005. Figure 5D ). The incidence of arthritis and the arthritis score were significantly increased (Figures 5E,F) . There was a marked increase in the levels of IL-17, FRA1, and JUNB in the spleen (Figure 5G) . The relative mRNA level of the osteoclastogenic marker tartrate-resistant acid phosphatase was significantly higher (Figure 5H) , while CII-specific T-cell proliferation and IgG production were also increased (Figures 5I-K) . Overexpression of FRA1/JUNB profoundly increased CIA S3C,D in Supplementary Material). These findings suggest that the FRA1-JUNB complex plays a major role in the development of CIA, likely through the induction of Th17 cell differentiation.
expression and Potential Functions of Fra1 and JUnB in ra Patients
We demonstrated in vivo roles of FRA1 and JUNB in mice with CIA, an animal disease model for RA. To confirm the roles of FRA1 and JUNB in patients with RA, FRA1 was overexpressed in CD4 + T cells isolated from healthy controls. FRA1 overexpression increased the proportion of IL-17-producing CD4 + T cells during Th17 polarization (Figure 6A ). These cells produced significantly higher levels of IL17a mRNA and cytokines ( Figure 6B) . Fra1 silencing decreased IL17a mRNA levels and IL-17 secretion (Figure 6C ). There were significantly increased the transcription levels of Fra1 and Junb among peripheral blood mononuclear cells (PBMCs) and synovial fluid mononuclear cells (SFMCs) from RA patients compared with PBMCs from healthy controls ( Figure 6D) . Junb was also upregulated in RA patients. When
Fra1 was silenced in CD4 + T cells isolated from SFMCs of RA patients, IL-17 secretion was decreased during Th17 polarization ( Figure 6E) . The expression of both FRA1 and JUNB was particularly high in the inflamed synovium of RA patients, a region enriched with inflammatory immune cells ( Figure 6F) . Of note, FRA1, JUNB, and phosphorylated STAT3 were colocalized in the inflamed synovium, which further supported our in vitro experimental results. A schematic illustration of the inflammatory signaling pathway induced by FRA1/JUNB is shown in Figure 6G . Th17 conditioning induces an inflammatory signal by promoting FRA1/JUNB. The inflammatory response is mediated by activation of STAT3, which regulates genes involved in Th17 cell differentiation. This cascade induces excessive inflammation and autoimmunity resulting in RA.
DiscUssiOn
Although FRA1 and JUNB may have modulatory activity in the immune inflammatory response (18, 19) , there is currently no evidence in the literature to support this notion in autoimmune disorders mediated by STAT3 and Th17 cells. In this study, we found evidence of previously unidentified functions of FRA1 and JUNB in Th17 cell differentiation and autoimmune disease. We investigated the modulatory function and underlying mechanisms of FRA1 and JUNB in a murine model of inflammatory arthritis. The predominant conclusion from this study was that FRA1 and JUNB exacerbate inflammation via the induction of Th17 cells. To our knowledge, this is the first study to implicate FRA1 and JUNB directly in STAT3 activation and regulation of Th17 cell proliferation. These observations suggest a previously unidentified function of these factors in autoimmune disease. Activator protein 1 is comprised of dimers of FOS and JUN protein family members (31, 32) . The diverse functions of AP-1 family members result from heterodimer formation between the FOS and JUN proteins (33) . AP-1 is also involved in cell functions including proliferation, differentiation, and apoptosis. For example, the FRA2-JUND complex is involved in the terminal differentiation of granulosa cells into luteal cells (34) and T-cell activation (35) . Additionally, AP-1 factors may play important roles in autoimmune disease and Th17 cell differentiation. It was suggested that basic leucine zipper transcription factor, ATF-like (BATF), an AP-1 protein, leads to increased Th17 cell differentiation, whereas BATF deficiency results in IL-17 downregulation (12) . Loss of the AP-1 family member Fosl2 in T cells improved EAE severity via suppression of Th17 cell plasticity (36) . We performed an integrative analysis using RNA-Seq and ChIP-Seq data to identify key factors downstream of STAT3 involved in Th17 cell differentiation. This integrative analysis suggested that upregulation of Fra1 and Junb drives and promotes Th17 cell differentiation.
Signal transducer and activator of transcription 3-mediated IL-17 expression and Th17 cell differentiation involve AP-1 family proteins. Previous studies have shown a biological link between the STAT3 signaling pathway and the AP-1 family of transcription factors (12, 37, 38) . In particular, STAT3-mediated expression of BATF, an AP-1 subfamily member, is associated with Th17 cell differentiation (12) . In this study, RNA-Seq analysis showed that the expression of cFos and cJun was higher in naïve T cells. This suggests that AP-1 subtype switching from c-FOSc-JUN to FRA1/JUNB is essential for Th17 cell differentiation. It can also be postulated that activation of c-FOS-c-JUN must be suppressed in parallel with activation of FRA1/JUNB by STAT3 during polarization toward the Th17 subtype. The present study identified an AP-1 complex comprising FRA1 and JUNB, which appears to function as a key factor downstream of STAT3 in Th17 cell differentiation. It appears that AP-1 subtype switching, particularly from c-FOS, FOSB, and c-JUN to FRA1 and JUNB, is required for STAT3-mediated Th17 cell differentiation.
The AP-1 family includes the c-JUN and c-FOS proteins, which play important roles in IL-17 expression and Th17 cell functions. It has been demonstrated that BATF binds to intergenic components in the IL17a locus and to IL17 promoters, both of which are essential for Th17 differentiation (12) . Additionally, the BATF-JUNB and BATF-JUND complexes have been shown to cooperate with IRF4 in Th17 cells to promote transcription of IL17 (39) . The c-JUN transcription factor that heterodimerizes with c-FOS to generate the AP-1 transcription factor complex is involved in suppression of IL-17 production in developing Th17 cells (16, 22) . FRA2 is also a negative regulator of IL-17 (36) . We observed that overexpression of FRA2 decreased the expression of IL17a in a promoter-fused luciferase reporter assay (data not shown). We also found that expression levels of c-Fos and c-Jun were significantly reduced, whereas Batf expression was increased in Th17 cells compared with naïve T cells. Overexpression of c-Fos and c-Jun significantly decreased IL17 mRNA levels. The FRA1-JUNB complex directly activates expression of IL-17, a cytokine produced by Th17 cells. This complex plays a role in promoting the expression of other cytokines associated with Th17 cells, such as IL-21 and IL-22, by directly binding to their promoter regions. These results suggest that FRA1 and JUNB are involved in IL-17 production and Th17 cell differentiation.
Although FRA1/JUNB and c-FOS/c-JUN compete for the same AP-1-binding sites within the IL17a promoter, we found in this study that IL17a promoter activity was increased by FRA1 and JUNB overexpression but decreased by c-FOS and c-JUN overexpression. We observed an interaction between p-STAT3 and p-FRA1 or p-JUNB in Th17 cells; therefore, FRA1/JUNB and c-FOS/c-JUN may be involved in AP-1 subtype switching. Additionally, p-FRA1 binds to p-JUNB in Th17 cells. Further study is needed to confirm the AP-1 subtype switching factors involved and the mechanism of interaction between p-FRA1 and p-JUNB in Th17 cells.
This study has certain limitations. One is that the animal studies were conducted using FRA1/JUNB-1 overexpression and knockdown vectors. Adoptive transfer studies in conditional overexpression and knockout mice are required to confirm that FRA1/JUNB-1 regulates CD4 + T cells, leading to autoimmune arthritis. Nonetheless, this study is the first to demonstrate functions of FRA1/JUNB-1 in Th17 cell differentiation and autoimmune arthritis. Future studies using adoptive transfer models with CD4 + T cells differentially expressing FRA1/JUNB-1 are required to validate our data more precisely.
Uncontrolled Th17 cell activation is responsible for the onset of several autoimmune diseases. Th17 cells cause tissue injury via production of IL-17, as observed in CIA mouse models of disease. The present study showed that the FRA1-JUNB complex plays a central role in the development of RA, which is a Th17-mediated autoimmune disease. The FRA1-JUNB complex may be clinically relevant as it functions as a Th17 cell-specific regulator of proinflammatory cytokine production in CIA mouse models and hence RA. In the RA mouse model used in this study, FRA1/ JUNB overexpression resulted in the development of severe inflammatory symptoms and augmented expression of IL-17 in mice. Notably, this has fueled interest in the genetic importance of FRA1/JUNB in human RA in the context of promoted STAT3 activity. FRA1 overexpression activated Th17 cell differentiation in PBMCs from healthy controls; however, FRA1 silencing downregulated IL-17 production in SFMCs from RA patients. This may indicate the potential of the FRA1-JUNB complex as a therapeutic target in human autoimmune disease. In conclusion, our results suggest a previously unidentified function of FRA1/JUNB in T-cell-mediated autoimmune diseases. FRA1/JUNB directly modulates STAT3 activation and Th17 cell differentiation. Our 
